HMT (Xiamen) New Technical Materials Co., Ltd (603306.SS)
CNY 30.43
(5.08%)
CNY 30.43
(5.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.05 Billion | 1.63 Billion | 1.2 Billion | 949.54 Million | 985.71 Million | 983.26 Million |
| Cost of Revenue | 1.46 Billion | 1.11 Billion | 766.77 Million | 609.03 Million | 634.83 Million | 587.61 Million |
| Gross Profit | 589.54 Million | 526.82 Million | 439.22 Million | 340.51 Million | 350.88 Million | 395.64 Million |
| Operating Expenses | 329.93 Million | 259.09 Million | 247.73 Million | 109.16 Million | 114.1 Million | 113.35 Million |
| Selling, General and Administrative Expenses | 212.81 Million | 134.13 Million | 115.7 Million | 19.26 Million | 30.54 Million | 34.02 Million |
| Research and Development Expenses | 95.65 Million | 81.65 Million | 57.16 Million | 46.27 Million | 44.47 Million | 40.83 Million |
| Other Expenses | 21.47 Million | 43.3 Million | 74.86 Million | 43.61 Million | 39.08 Million | 38.49 Million |
| Cost and Expenses | 1.79 Billion | 1.36 Billion | 1.01 Billion | 718.19 Million | 748.93 Million | 700.97 Million |
| Operating Income | 259.61 Million | 230.79 Million | 201.35 Million | 232.26 Million | 277.42 Million | 322.28 Million |
| Interest Expense | 10.41 Million | 1.55 Million | 1.26 Million | 1.05 Million | 347.5 Thousand | 58.76 Thousand |
| Income Tax Expense | 32.36 Million | 35.02 Million | 25.25 Million | 30.46 Million | 40.68 Million | 46.24 Million |
| Earnings before Tax | 260.7 Million | 230.48 Million | 200.49 Million | 231.48 Million | 277.47 Million | 322.68 Million |
| Net Income | 242.01 Million | 198.45 Million | 176.11 Million | 201.01 Million | 236.79 Million | 276.43 Million |
| Earnings Per Share Basic | 0.75 | 0.65 | 0.57 | 0.65 | 0.77 | 0.90 |
| Earnings Per Share Diluted | 0.74 | 0.61 | 0.57 | 0.65 | 0.77 | 0.90 |
| Weighted Average Shares Outstanding | 323.97 Million | 307.68 Million | 307.01 Million | 307.01 Million | 307.01 Million | 307.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 325.28 Million | 324.28 Million | 307.01 Million | 307.01 Million | 307.01 Million | 307.15 Million |
| Gross Margin | 0.29 | 0.32 | 0.36 | 0.36 | 0.36 | 0.40 |
| EBIT Margin | 0.19 | 0.22 | 0.25 | 0.39 | 0.37 | 0.40 |
| Profit Margin | 0.12 | 0.12 | 0.15 | 0.21 | 0.24 | 0.28 |
| EBITDA | 395.08 Million | 343.51 Million | 300.51 Million | 323.26 Million | 358.31 Million | 389.83 Million |
| Earnings Before Tax Margin | 0.13 | 0.14 | 0.17 | 0.24 | 0.28 | 0.33 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 568.67 Million | 499.51 Million | 469.28 Million | 2.05 Billion | 597.76 Million | 565.63 Million |
| Cost of Revenue | 398.49 Million | 354.58 Million | 325.48 Million | 1.42 Billion | 403.27 Million | 381.76 Million |
| Gross Profit | 170.18 Million | 144.92 Million | 143.79 Million | 629.46 Million | 194.48 Million | 183.86 Million |
| Operating Expenses | 84.9 Million | 67.08 Million | 61.15 Million | 299.05 Million | 64.31 Million | 82.95 Million |
| Selling, General and Administrative Expenses | 51.42 Million | -116.75 Thousand | 45.28 Million | - | -69.35 Million | 113.04 Million |
| Research and Development Expenses | 26.66 Million | 23.4 Million | 21.28 Million | - | 26.44 Million | 25.57 Million |
| Other Expenses | -6.82 Million | -11.47 Thousand | 2430.00 | 1.09 Million | 712 Thousand | 475.58 Thousand |
| Cost and Expenses | 483.4 Million | 421.67 Million | 386.64 Million | 1.72 Billion | 467.58 Million | 464.72 Million |
| Operating Income | 85.27 Million | 96.23 Million | 64.23 Million | 259.61 Million | 96.85 Million | 78.42 Million |
| Interest Expense | 6.45 Million | 639.11 Thousand | 11.69 Million | 10.3 Million | 8.29 Million | 1.39 Million |
| Income Tax Expense | 11.15 Million | 16.91 Million | 12.7 Million | 32.36 Million | 6.87 Million | 11.84 Million |
| Earnings before Tax | 87.98 Million | 96.22 Million | 64.23 Million | 260.7 Million | 97.57 Million | 78.9 Million |
| Net Income | 63.81 Million | 78.43 Million | 53.9 Million | 242.01 Million | 93.41 Million | 71.6 Million |
| Earnings Per Share Basic | 0.20 | 0.25 | 0.18 | - | 0.29 | 0.22 |
| Earnings Per Share Diluted | 0.19 | 0.25 | 0.18 | - | 0.29 | 0.21 |
| Weighted Average Shares Outstanding | 319.07 Million | 314.06 Million | 301.11 Million | 323.97 Million | 326.8 Million | 323.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 335.87 Million | 314.06 Million | 302.81 Million | 325.28 Million | 326.8 Million | 340.95 Million |
| Gross Margin | 0.30 | 0.29 | 0.31 | 0.31 | 0.33 | 0.33 |
| EBIT Margin | 0.17 | 0.20 | 0.17 | - | 0.25 | 0.17 |
| Profit Margin | 0.11 | 0.16 | 0.11 | 0.12 | 0.16 | 0.13 |
| EBITDA | 94.44 Million | 101.46 Million | 77.69 Million | - | 147.57 Million | 94.91 Million |
| Earnings Before Tax Margin | 0.15 | 0.19 | 0.14 | 0.13 | 0.16 | 0.14 |
6808
CNGL
SORIANAB
NYC
CEDO3
NDL